» Articles » PMID: 38819553

Trends in Incidence and Mortality of Early-onset Cancer in Germany Between 1999 and 2019

Overview
Journal Eur J Epidemiol
Specialty Public Health
Date 2024 May 31
PMID 38819553
Authors
Affiliations
Soon will be listed here.
Abstract

Evidence on the recent temporal trend in the incidence and mortality of early-onset cancer, i.e., cancer diagnosed at ages of < 50 years, in Germany is scarce. To estimate the temporal trend in the incidence and mortality of early-onset cancer in Germany between 1999 and 2019. Input data were obtained from the Centre for Cancer Registry Data (Zentrum für Krebsregisterdaten, ZfKD). The analysis comprised all ages until 50 years and all types of cancer classified by the International Classification of Diseases (ICD-10)-codes C00-C97 (excl. C44). Temporal trends were estimated using negative binomial regression, differentiated by sex and cancer type. Between 1999 and 2019 in Germany, we observed stable or slightly increasing trends (0% and 1%) in the incidence of all early-onset cancers combined (C00-C97) for men and women, respectively, and strict declines in the mortality for both, men and women (-2% and - 3%). However, the trends differ largely with respect to sex and the individual cancer types. Early-onset cancer should be closely monitored to see whether stable and decreasing trends in the incidence and mortality continue. Knowing that despite decreasing incidence, the prevalence of a disease can rise due to their interplay with mortality, we recommend to maintain precise surveillance, efforts in prevention and early detection, as well as appropriate investments into healthcare resources, research and development.

Citing Articles

Trends in incidence and mortality of early-onset cancer in Germany between 1999 and 2019.

Voeltz D, Baginski K, Hornberg C, Hoyer A Eur J Epidemiol. 2024; 39(7):827-837.

PMID: 38819553 PMC: 11343808. DOI: 10.1007/s10654-024-01134-4.

References
1.
Xu J, Lin Y, Yang M, Zhang L . Statistics and pitfalls of trend analysis in cancer research: a review focused on statistical packages. J Cancer. 2020; 11(10):2957-2961. PMC: 7086268. DOI: 10.7150/jca.43521. View

2.
Schmutzler R, Schmitz-Luhn B, Borisch B, Devilee P, Eccles D, Hall P . Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk Factors. Breast Care (Basel). 2022; 17(2):208-223. PMC: 9149472. DOI: 10.1159/000517182. View

3.
Katalinic A, Eisemann N, Kraywinkel K, Noftz M, Hubner J . Breast cancer incidence and mortality before and after implementation of the German mammography screening program. Int J Cancer. 2019; 147(3):709-718. DOI: 10.1002/ijc.32767. View

4.
Olivieri M, Konigs C, Heller C, Horneff S, Oldenburg J, Halimeh S . Prevalence of Obesity in Young Patients with Severe Haemophilia and Its Potential Impact on Factor VIII Consumption in Germany. Hamostaseologie. 2019; 39(4):355-359. DOI: 10.1055/s-0039-1677874. View

5.
Cortese S, Song M, Farhat L, Yon D, Lee S, Kim M . Incidence, prevalence, and global burden of ADHD from 1990 to 2019 across 204 countries: data, with critical re-analysis, from the Global Burden of Disease study. Mol Psychiatry. 2023; 28(11):4823-4830. DOI: 10.1038/s41380-023-02228-3. View